Cholecystokinin (CCK) is a gastrointestinal hormone that could potentially be used as an anti-obesity drug, as evidenced by the lowering of food intake observed after administration to rodents [2, 3], pigs [4], monkeys [5] and both lean and obese humans [6, 7]. Here, CCK is linked to obesity due to melanocortin 4 receptor deficiency.